Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection

Transplant Immunology

Volumn 14, Issue 2, 2005, Pages 117-121

  Slavcev, Antonij ^a   Lácha, Jiri ^a   Honsová, Eva ^a   Sajdlová, Helena ^a   Lodererová, Alena ^a   Vitko, Stefan ^a   Skibová, Jelena ^a   Striz, Ilja ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Antibodies; ELISA; Flow cytometry; HLA; Kidney transplantation; Soluble CD30

Indexed keywords

CD30 ANTIGEN; CYCLOSPORIN A; HLA ANTIBODY; HLA ANTIGEN CLASS 2; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ANTIGEN DETECTION; ARTICLE; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIENCE; FACTORIAL ANALYSIS; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; INCIDENCE; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PATIENT; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADULT; ANTIBODIES; ANTIGENS, CD30; BIOLOGICAL MARKERS; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 20344404967     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2005.03.014     Document Type: Article

References (20)

1. R.M. McKenna, S.K. Takemoto, and P.I. Terasaki Anti-HLA antibodies after solid organ transplantation Transplantation 69 3 2000 319 326
2. R.W. O'Rourke, R.W. Osorio, C.E. Freise, C.D. Lou, M.R. Garovoy, and P. Bacchetti Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants Clin Transplant 14 2 2000 167 173
3. J.E. Worthington, S. Martin, D.M. Al Husseini, P.A. Dyer, and R.W. Johnson Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome Transplantation 75 7 2003 1034 1040
4. C. Susal, S. Pelzl, B. Dohler, and G. Opelz Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30 J Am Soc Nephrol 13 6 2002 1650 1656
5. C. Susal, S. Pelzl, and G. Opelz Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30 Transplantation 76 8 2003 1231 1232
6. S. Pelzl, G. Opelz, V. Daniel, M. Wiesel, and C. Susal Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection Transplantation 75 3 2003 421 423
7. R. Horie, and T. Watanabe CD30: expression and function in health and disease Semin Immunol 10 6 1998 457 470
8. F. Mackay, and S. Kalled TNF ligands and receptors in autoimmunity: an update Curr Opin Immunol 14 6 2002 783 790
9. L.C. Racusen Pathology and the allo-immune response Am J Transplant 3 12 2003 1461 1462
10. A. Slavcev, J. Lacha, E. Honsova, H. Sajdlova, A. Lodererova, and S. Vitko Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test Transpl Int 16 12 2003 872 878
11. S. Martin, and F. Claas Antibodies and crossmatching for transplantation P.A. Dyer D. Middleton Histocompatibility Testing 1993 Oxford Univ. Press Oxford 81 105
12. C. Brown, and C. Navarette Screening for HLA-specific antibodies J.L. Bidwell C. Navarette Histocompatibility Testing 2000 Imperial College Press London 65 98
13. P.I. Terasaki Humoral theory of transplantation Am J Transplant 3 6 2003 665 673
14. P.I. Terasaki, and M. Ozawa Predicting kidney graft failure by HLA antibodies: a prospective trial Am J Transplant 4 3 2004 438 443
15. M.A. Pascual, M. Crespo, and N. Tolkoff-Rubin Progress in understanding humoral rejection in kidney transplantation: implications for patient management Nefrologia 21 4 2001 327 331
16. M. Crespo, M. Pascual, N. Tolkoff-Rubin, S. Mauiyyedi, A.B. Collins, and D. Fitzpatrick Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics Transplantation 71 5 2001 652 658
17. S. Mauiyyedi, and R.B. Colvin Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment Curr Opin Nephrol Hypertens 11 6 2002 609 618
18. C. Schönemann, J. Groth, S. Leverenz, and G. May HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance Transplantation 65 11 1998 1519 1523
19. J.C. Scornik, W. Clapp, P.R. Patton, W.J. Van der Werf, A.W. Hemming, and A.I. Reed Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive Transplantation 71 8 2001 1098 1102
20. G. Fernandez Fresnedo, J.M. Pastor, M. Lopez Hoyos, J.C. Ruiz, J.A. Zubimendi, and Gonzalez Cotorruelo Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival Nephrol Dial Transplant 18 5 2003 990 995